■ CD117 モノクローナル抗体(品番:65054-1-Ig)

図1. CD117抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC Anti-Mouse CD45R (B220) (APC-65139, Clone: RA3-6B2), 1 ug Anti-Mouse CD117 (65054-1-Ig, Clone: 2B8) and FITC anti-rat IgG2b Antibody at dilution 1:200. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC Anti-Mouse CD45R (B220) (APC-65139, Clone: RA3-6B2), 1 ug rat IgG2b isotype control and FITC anti-rat IgG2b Antibody at dilution 1:200. Cells were not fixed.
■ CD117 モノクローナル抗体(品番:FITC-65054)

図1. CD117抗体とCD11B抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC-Anti-Mouse CD11b (APC-65055, Clone:M1/70) and 1.00 ug FITC-Anti-Mouse CD117 (FITC-65054, Clone:2B8). Sample were not fixed.
図2. アイソタイプコントロール抗体とCD11B抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC-Anti-Mouse CD11b (APC-65055, Clone:M1/70) and 1.00 ug FITC-rat IgG2b isotype control antibody. Sample were not fixed.
■ CD117 モノクローナル抗体(品番:PE-65054)

図1. CD117抗体とCD11B 抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC-Anti-Mouse CD11b (APC-65055, Clone:M1/70) and 1.00 ug PE-Anti-Mouse CD117 (PE-65054, Clone:2B8). Sample were not fixed.
図2. アイソタイプコントロール抗体とCD11B抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC-Anti-Mouse CD11b (APC-65055, Clone:M1/70) and 1.00 ug PE-rat IgG2b isotype control antibody. Sample were not fixed.
■ CD117 モノクローナル抗体(品番:APC-65054)

図1. CD117抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with FITC Anti-Mouse CD45R (B220) (FITC-65139, Clone: RA3-6B2) and 0.20 ug APC Anti-Mouse CD117 (APC-65054, Clone: 2B8). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with FITC Anti-Mouse CD45R (B220) (FITC-65139, Clone: RA3-6B2) and 0.20 ug APC-Rat IgG2b isotype control antibody. Cells were not fixed.
■ CD117 モノクローナル抗体(品番:CL488-65054)

図1. CD117抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC Anti-Mouse CD45R (B220) (APC-65139, Clone: RA3-6B2) and 5.00 ul CoraLite®488-conjugated Anti-Mouse CD117 (CL488-65054, Clone: 2B8). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC Anti-Mouse CD45R (B220) (APC-65139, Clone: RA3-6B2) and CoraLite®488-conjugated Rat IgG2b isotype control antibody. Cells were not fixed.
■ CD117 モノクローナル抗体(品番:CL594-65054)

図1. CD117抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC Anti-Mouse CD45R (B220) (APC-65139, Clone: RA3-6B2) and 5.00 ul CoraLite®594-conjugated Anti-Mouse CD117 (CL594-65054, Clone: 2B8). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with APC Anti-Mouse CD45R (B220) (APC-65139, Clone: RA3-6B2) and CoraLite®594-conjugated Rat IgG2b isotype control antibody. Cells were not fixed.
■ CD117 モノクローナル抗体(品番:CL647-65054)

図1. CD117抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with FITC Anti-Mouse CD45R (B220) (FITC-65139, Clone: RA3-6B2) and 5.00 ul CoraLite®647-conjugated Anti-Mouse CD117 (CL647-65054, Clone: 2B8). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD45R抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with FITC Anti-Mouse CD45R (B220) (FITC-65139, Clone: RA3-6B2) and CoraLite®647-conjugated Rat IgG2b isotype control antibody. Cells were not fixed.